In this study, the Authors found that acute immunotherapy escalation was associated with lower early and mid-term relapses in pediatric MOGAD patients, suggesting the first attack may represent a therapeutic opportunity to influence disease trajectory.
See the full paper here: https://www.neurology.org/doi/10.1212/WNL.0000000000218405?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed